New York Assembly Bill A03545

New York 2025-2026 Regular Session

• Introduced: 1/28/25
• Refer: 1/28/25
• Refer: 1/7/26

Caption

Creates a ten year live kidney donor follow-up study which includes a one thousand dollars per year stipend for participants; provides two thousand dollars for all kidney donors for health-related expenses.

Summary

Bill A03545 proposes the establishment of a ten-year follow-up study for living kidney donors in New York, aimed at assessing their health post-donation. The New York Department of Health will contract a qualified research team to conduct this prospective study, which will track the health outcomes of kidney donors who donate between January 1, 2026, and December 31, 2030. Participants who agree to provide follow-up data will receive a stipend of $1,000 for each year they participate in the study. Additionally, for the first five years after donation, kidney donors will be entitled to receive up to $2,000 to cover copayments and other health-related expenses.

Impact

The bill amends the public health law to include provisions for a systematic study of living kidney donors, which is expected to enhance understanding of the long-term health effects of kidney donation. This could lead to improved policies and support for kidney donors in New York, potentially influencing future legislation related to organ donation and donor health care. By providing financial support for health-related expenses, the bill aims to alleviate some of the financial burdens faced by donors, thereby encouraging more individuals to consider becoming living donors.

Sentiment

The sentiment surrounding Bill A03545 appears to be supportive, as it addresses a critical area of public health by focusing on the well-being of living kidney donors. The provision for financial stipends and health-related expense coverage is viewed positively, as it acknowledges the potential risks and costs associated with kidney donation. However, there may be concerns regarding the funding and implementation of the study, which could be points of discussion among stakeholders.

Contention

Notable points of contention may arise regarding the funding sources for the stipends and health-related expenses provided to donors, as well as the overall effectiveness and scope of the proposed study. Some stakeholders may question whether the financial incentives are sufficient to encourage participation or if they might lead to unintended consequences. Additionally, there could be discussions about the ethical implications of compensating donors and the long-term impact of the study's findings on public health policy.